OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Insulin Resistant

Insulin Resistant


As per available reports about 13 Relevant Journal, 21 Conferences, 20 National Symposiums are presently dedicated exclusively to Insulin Resistance and about 82 Open Access Articles are being published on Insulin Resistance.

Insulin resistance (IR) is a physiological condition in which cells fail to respond to the normal actions of the hormone insulin. The body produces insulin, but the cells in the body become resistant to insulin and are unable to use it as effectively, leading to hyperglycaemia. Beta cells in the pancreas subsequently increase their production of insulin, further contributing to hyperinsulinemia. This often remains undetected and can contribute to a diagnosis of Type 2 Diabetes or latent autoimmune diabetes of adults. One of insulin's functions is to regulate delivery of glucose into cells to provide them with energy Insulin resistant  cells cannot take in glucose, amino acids and fatty acids. Thus, glucose, fatty acids and amino acids 'leak' out of the cells. A decrease in insulin/glucagon ratio inhibits glycolysis which in turn decreases energy production. The resulting increase in blood glucose may raise levels outside the normal range and cause adverse health effects, depending on dietary conditions. Certain cell types such as fat and muscle cells require insulin to absorb glucose. When these cells fail to respond adequately to circulating insulin, blood glucose  levels rise. The liver helps regulate glucose levels by reducing its secretion of glucose in the presence of insulin. This normal reduction in the liver’s glucose production may not occur in people with insulin resistance. Insulin resistance in muscle and fat cells reduces glucose uptake (and also local storage of glucose as glycogen and triglycerides, respectively), whereas insulin resistance in liver cells results in reduced glycogen synthesis and storage and also a failure to suppress glucose production and release into the blood. Insulin resistance normally refers to reduced glucose-lowering effects of insulin. However, other functions of insulin can also be affected.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope & Importance

Randomised controlled trials have shown that maintenance of blood glucose levels below 110 mg/dl with intensive insulin therapy reduces mortality and morbidity of surgical and medical critically ill patients. An absolute reduction in the risk of death of 3-4 % is expected in intention-to-treat analysis, but the survival benefit increases when treatment is continued for at least a few days.

Old Content

Insulin is a hormone made by the pancreas that allows your body to use sugar (glucose) from carbohydrates in the food that you eat for energy or to store glucose for future use. Insulin helps keeps your blood sugar level from getting too high (hyperglycemia) or too low (hypoglycemia).

The cells in your body need sugar for energy. However, sugar cannot go into most of your cells directly. After you eat food and your blood sugar level rises, cells in your pancreas (known as beta cells) are signaled to release insulin into your bloodstream. Insulin then attaches to and signals cells to absorb sugar from the bloodstream. Insulin is often described as a “key,” which unlocks the cell to allow sugar to enter the cell and be used for energy. If you have more sugar in your body than it needs, insulin helps store the sugar in your liver and releases it when your blood sugar level is low or if you need more sugar, such as in between meals or during physical activity. Therefore, insulin helps balance out blood sugar levels and keeps them in a normal range. As blood sugar levels rise, the pancreas secretes more insulin.

If your body does not produce enough insulin or your cells are resistant to the effects of insulin, you may develop hyperglycemia (high blood sugar), which can cause long-term complications if the blood sugar levels stay elevated for long periods of time.

Insulin Treatment for Diabetes

People with type 1 diabetes cannot make insulin because the beta cells in their pancreas are damaged or destroyed. Therefore, these people will need insulin injections to allow their body to process glucose and avoid complications from hyperglycemia.

People with type 2 diabetes do not respond well or are resistant to insulin. They may need insulin shots to help them better process sugar and to prevent long-term complications from this disease. Persons with type 2 diabetes may first be treated with oral medications, along with diet and exercise. Since type 2 diabetes is a progressive condition, the longer someone has it, the more likely they will require insulin to maintain blood sugar levels.

Various types of insulin are used to treat diabetes and include:

•           Rapid-acting insulin:It starts working approximately 15 minutes after injection and peaks at approximately 1 hour but continues to work for two to four hours. This is usually taken before a meal and in addition to long-acting insulin.

•           Short-acting insulin: It starts working approximately 30 minutes after injection and peaks at approximately 2 to 3 hours but will continue to work for three to six hours. It is usually given before a meal and in addition to long-acting insulin.

•           Intermediate-acting insulin: It starts working approximately 2 to 4 hours after injection and peaks approximately 4 to 12 hours later and continues to work for 12-18 hours. It is usually taken twice a day and in addition to rapid- or short-acting insulin.

•           Long-acting insulin: It starts working after several hours after injection and works for approximately 24 hours. If necessary, it is often used in combination with rapid- or short-acting insulin.

Market Analysis

The global human insulin market crossed $23 billion in 2013 and is poised to grow at a high double-digit CAGR from 2014 to 2019.The market is segmented based on products, and types of insulin. Based on products, the global human insulin market is segmented into biologics and biobetters, and biosimilars/biogenerics. Human insulin market is also segmented into traditional and modern human insulin. Of these, modern human insulin and biosimilarswill be the fastest-growing market in the next five years.The major factors propelling this growth are cost effective treatment offered while using modern human insulin and low price of biosimilars/biogeneric drugs of human insulin thereby stimulating the demand for biosimilar human insulin products.

List of best International Conferences:

  1. 4th Nephrology Conference
    September 14-16, 2015, USA
  2. 3rd Endocrinology  Conference
    November  02-04,  2015, USA
  3. 11th Targeting  Diabetes  Conference
    October  17-19,  2016, Malaysia
  4. 6th Endocrinology  Conference
    November  28-30,  2016;  USA
  5. 6th Diabetes Conference
    November  02-04,  2015, UAE
  6. 8th Euro  Diabetes  Conference
    November  03-05,  2015, Spain
  7. 10th European  Diabetes  Conference
    July  14-16,  2016, UK
  8. 7th Indo Diabetes Conference
    November  23-25,  2015, India
  9. Thyroid Disorders  and treatment Conference
    February 29-March 02, 2016,  USA
  10. 9th Diabetologists Conference
    June 06-08, 2016, USA. 
  11. 2nd  Hormones  and  Steroids  Conference
    June  23-25,  2016, USA
  12. 11th Asia  Pacific  Diabetes  Conference
    July  11-13,  2016, Australia
  13. 12th Diabetes  Conference
    September  29-October  1,  2016,  Canada
  14. 13th Diabetes  Conference 
    August  08-10,  2016, UK
  15. Metabolic Syndrome Conference
    October  20-22,  2016, UAE 

Diabetes Societies

  1. American Diabetes Association
  2. Diabetes India Association
  3. Austrian Diabetes Association. 
  4. Flemish Diabetes Association
  5. Association of Juvenile Diabetes
  6. Canadian Diabetes Association
  7. Juvenile Diabetes Foundation of Chile
  8. Diabetological Colombian Federation
  9. Croatian Diabetes Association
  10. Union of Diabetics of Czech Republic
  11. Estonian Diabetes Association. 
  12. Finnish Diabetes Association German Diabetes Union.
  13. Hellenic Diabetes Association
  14. Hong Kong Diabetes Federation. 
  15. Icelandic Diabetic Association
  16. Diabetic Association of India
  17. Diabetes Federation of Ireland
  18. The Diabetes Association (Italy)
  19. Japan Diabetes Society
  20. Korean Diabetes Association

Companies related to Insulin

  1. Orban Biotech
  2. LLC Novo Nordisk
  3. Cisbio Bioassays
  4. SemBioSys
  5. Ceres Chemical Co. Inc.
  6. Eli Lilly and Company
  7. signum Biosciences, Inc
  8. GlaxoSmithKline plc
  9. Proteome Sciences
  10. Centerchem Inc.
  11. Johnson & Johnson Services, Inc
  12. Treeline
  13. Whole Foods
  14. The Diabetic Boot Company Limited
  15. Novo Nordisk
  16. Sanofi
  17. Bristol-Meyers Squibb
  18. AstraZeneca
  19. Aventis
  20. Byetta

 

 

This page will be updated regularly.

This page was last updated on 11th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising